Abstract:4625 Angiogenesis, the formation of new blood vessels from surrounding vasculature, is an integral event in tumor progression. We have shown that calcitriol (1, 25-dihydroxycholecalciferol), the major active form of vitamin D, is anti-proliferative for tumor cells and endothelial cells isolated from tumors. Using vitamin D receptor (VDR)-knockout mice, we demonstrated that calcitriol-mediated growth inhibition in tumor-derived endothelial cells is dependent on the expression of VDR. Here, we further show that VDR may play a major role in development of blood vessel during angiogenesis. We implanted transgenic adenocarcinoma mouse prostate (TRAMP) C2 cells and Matrigel plug subcutaneously into both VDR wild type and knockout mice. In VDR KO mice, the blood vessels found in the tumor xenografts and Matrigel plugs were significantly enlarged when compared to those in VDR WT mice. Vessel lumen coverage in the tumor was approximately 1% in VDR WT mice and 25% in VDR KO mice. Similarly, vessel lumen coverage in Matrigel plugs was about 1% in VDR WT mice but was 34% in VDR KO mice. Interestingly, these observations were not found in normal organs such as heart and muscle. Contrast-enhanced MRI revealed increased vascular volume (0.2597 + 0.013) of TRAMP tumors implanted in VDR KO mice compared to WT mice (0.1618 + 0.034). Tumors implanted in VDR KO mice also showed a linear increase (r2 = 0.8661) in permeability over time compared to those in wild-types (r2 = 0.5439). Double staining of CD31 and alpha-SMA tissue sections suggests that vessels in tumor from VDR KO mice have lower pericyte coverage, which might indicate more immature vessels. Since others have shown that calcitriol can regulate vascular endothelial growth factor (VEGF) and platelet-derived growth factor-BB (PDGF-BB) expression, we then measured these growth factor levels in tumor extracts from both VDR WT and KO mice. Using ELISA, there was significant higher VEGF but not PDGF observed in tissues from VDR KO mice. These results indicate that ablation of VDR could play a major role in vessel development and maturation in tumor angiogenesis by regulating VEGF signaling pathway. Supported by NCI grants CA67267, CA95045 and CA85142 and DOD grant PCRP050202.

The P38 and JNK Pathways Cooperate to Trans-Activate Vitamin D Receptor Via C-Jun/ap-1 and Sensitize Human Breast Cancer Cells to Vitamin D(3)-induced Growth Inhibition.

Jnk/Ap-1 Pathway is Involved in Tumor Necrosis Factor-Alpha Induced Expression of Vascular Endothelial Growth Factor in Mcf7 Cells

The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm

Dehydroascorbic acid taken up by glucose transporters stimulates estradiol production through inhibition of JNK/c-Jun/AP1 signaling in JAR cells.

Direct Activation of TACE-Mediated Ectodomain Shedding by P38 MAP Kinase Regulates EGF Receptor-Dependent Cell Proliferation

In Vivo Function of Vitamin D Receptor (VDR) in Tumor Angiogenesis

JNK1 as a signaling node in VDR-BRAF induction of cell death in AML

XBP1s Activates METTL3/METTL14 for ER-phagy and Paclitaxel Sensitivity Regulation in Breast Cancer

A novel function of p38-regulated/activated kinase in endothelial cell migration and tumor angiogenesis

JNK-Dependent cJun Phosphorylation Mitigates TGFβ- and EGF-Induced Pre-Malignant Breast Cancer Cell Invasion by Suppressing AP-1-Mediated Transcriptional Responses.

Vitamin D-3 Modulated Gene Expression Patterns In Human Primary Normal And Cancer Prostate Cells

Cyclic Strain Stress-induced Mitogen-activated Protein Kinase (MAPK) Phosphatase 1 Expression in Vascular Smooth Muscle Cells Is Regulated by Ras/Rac-MAPK Pathways

Vitamin D receptor induces oxidative stress to promote esophageal squamous cell carcinoma proliferation via the p53 signaling pathway

P38 Mitogen-Activated Protein Kinase Up-Regulates Nf-Kappa B Transcriptional Activation Through Rela Phosphorylation During Stretch-Induced Myogenesis

Genomically anchored vitamin D receptor mediates an abundance of bioprotective actions elicited by its 1,25-dihydroxyvitamin D hormonal ligand

Signal integration by JNK and p38 MAPK pathways in cancer development

Cutting Edge: Progesterone Directly Upregulates Vitamin D Receptor Gene Expression for Efficient Regulation of T Cells by Calcitriol

P38 Mitogen-activated Protein Kinase Mediates Hypoxia-Induced Vascular Endothelial Growth Factor Release in Human Endothelial Cells.

Tumor Necrosis Factor-Α Regulates Expression of Vascular Endothelial Growth Factor Via JNK and AP-1 Pathway in MCF-7 Cells

Vitamin D modulation of mitochondrial oxidative metabolism and mTOR enforces stress tolerance and anti-cancer responses

Role of Vitamin D Receptor in the Antiproliferative Effects of Calcitriol in Tumor-Derived Endothelial Cells and Tumor Angiogenesis In vivo